Clinical Trial Update: Safety and Efficacy Study Using Rexin-G for Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and efficacy study of Rexin-G for sarcoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Rexin-G

Snippet

Sponsor: Epeius Biotechnologies | Conditions: Sarcoma | Phase 1, Phase 2 | Status: COMPLETED